Diet induction of monocyte chemoattractant protein-1 and its impact on obesity

Obesity Research

Volumn 13, Issue 8, 2005, Pages 1311-1320

  Chen, Airu ^a   Mumick, Sheena ^a   Zhang, Chunsheng ^b   Lamb, John ^b   Dai, Hongyue ^b   Weingarth, Drew ^a   Mudgett, John ^a   Chen, Howard ^a   MacNeil, Douglas J ^a   Reitman, Marc L ^a   Qian, Su ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b ROSETTA INPHARMATICS   (United States)

Author keywords

Adipose; Chemokine; High fat diet; Inflammation; Macrophage

Indexed keywords

EID: 31044456061     PISSN: 10717323     EISSN: None     Source Type: Journal    
DOI: 10.1038/oby.2005.159     Document Type: Article

References (25)

1. Friedman JM, Halaas J. Leptin and the regulation of body weight in mammals. Nature. 1998;395:763-70.
2. Rosen BS, Cook KS, Yaglom J, et al. Adipsin and complement factor D activity: an immune-related defect in obesity. Science. 1989;244:1483-7.
3. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance. Science. 1993;259:87-90.
4. Ahima RS, Flier JS. Adipose tissue as an endocrine organ. Trends Endocrinol Metab. 2000;11:327-32.
5. Sartipy P, Loskuroff DJ. Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc Nad Acad Sci USA. 2003;100:7265-70.
6. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invent. 2003;12:1796-808.
7. Xu H, Barnes GT, Yang Q, et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest. 2003;112:1821-30.
8. Charo IF, Myers SJ, Herman A, Franci C, Connolly AJ Coughlin SR. Molecular cloning and functional expression of two monocyte chemoattractant protein 1 receptors reveals alternative splicing of the carboxyl-terminal tails. Proc Natl Acad Sci USA. 1994;91:2752-6.
9. Baggiolini M. Chemokines and leukocyte traffic. Nature. 1998;392:565-8.
10. Gerhardt CC, Romero IA, Cancello R, Camoin L, Stroberg AD. Chemokines control fat accumulation and leptin secretion by cultured human adipocytes. Mol Cell Endocrinol. 2001;175:81-92.
11. Takahashi K, Mizurarai S, Araki H, et al. Adipocity elevates plasma MCP-1 levels leading to the increased CD11b-positive monocytes in mice. J Biol Chem. 2003;278:46654-60.
12. -/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature. 1998;394:894-7.
13. Gu L, Okada Y, Clinton SK, et al. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol Cell. 1998;2:275-81.
14. Gosling J, Slaymaker S, Gu L, et al. MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B. J Clin Invest. 1999;103:773-8.
15. Kuziel WA, Morgan SJ, Dawson TC, et al. Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2. Proc Natl Acad Sci USA. 1997;94:12053-8.
16. van't Veer LJ, Hongyue D, van de Vijver, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature. 2002;415:530-6.
17. Hughes TR, Marton MJ, Jones AR, et al. Functional discovery via a compendium of expression profiles. Cell. 2000;102:109-26.
18. Warne JP. Tumor necrosis factor-a, a key regulator of adipose tissue mass. J Endocrinol. 2003;177:351-5.
19. Voros G, Maquoi E, Collen D, Lijnen HR. Differential expression of plasminogen activator inhibitor-1, tumor necrosis factor-α, TNF-α converting enzyme and ADAMTS family members in murine fat territories. Biochim Biophys Acta. 2003;1625:36-42.
20. Hildebrandt AL, Kelly-Sullivan DM, Black SC. Antiobesity effects of chronic cannabinoid CB1 receptor antagonist treatment in diet-induced obese mice. Eur J Pharmacol. 2003;462:125-32.
21. Cushing SD, Berliner JA, Valente AJ, et al. Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. Proc Natl Acad Sci USA. 1990;87:5134-8.
22. Xu H, Hirosumi J, Uysal KT, Guler AD, Hotamisligil GS. Exclusive action of transmembrane TNF-α in adipose tissue leads to reduced adipose mass and local but not systemic insulin resistance. Endocrinology. 2002;143:1502-11.
23. Wallenius V, Wallenius K, Ahren B, et al. Interleukin-6-deficient mice develop mature-onset obesity. Nature Med. 2002;8:75-9.
24. Sjöström CD, Lissner L, Sjöström L. Relationships between changes in body composition and changes in cardiovascular risk factors: the SOS intervention study. Obes Res. 1997;5:519-30.
25. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with life style intervention or metformin. N Engl J Med. 2002;346:393-403.